Eisai Co., Ltd.

Joining date
2011
Tokyo, Japan

Eisai Co., Ltd. is a global pharmaceutical company and a funding member of WIPO Re:Search. Eisai's corporate mission is to increase the benefits of healthcare to patients, their families, and consumers around the world. Eisai currently conducts various projects for research and development on NTDs such as Chagas disease, filariasis, leishmaniasis and mycetoma, as well as malaria and tuberculosis. Eisai is dedicated to taking proactive steps for improvement of access to medicines in developing and emerging countries through collaboration with global organizations such as the World Health Organization (WHO), and participates in various international consortiums to share compound libraries.

Read More
Diseases
Lymphatic filariasis
Malaria
Chagas disease
Leishmaniasis
Tuberculosis
Research areas
Drug
Active Labs
None available.
7 Assets
View Assets
14 Collaborations
View Collaborations